Statin Refill by Patient Portal Ups Adherence in Diabetes
Use of Kaiser Permanente's online patient portal to order statins improved adherence and LDLcholesterol levels albeit modestly among diabetes patients. Medscape Medical News
View ArticleMatinas BioPharma Announces Presentation at Biotech Showcase 2014 in San...
BEDMINSTER NJMarketwired January 10 2014 Matinas BioPharma Holdings Inc. an emerging biopharmaceutical company focused on the development and commercialization of omega3 fatty acidbased prescription...
View ArticleCVS Caremark Research Finds Optimal Adherence to Medications Prescribed...
WOONSOCKET R.I. Jan. 13 2014 PRNewswire &160;New research conducted by CVS Caremark NYSE CVS and Brigham and Women's Hospital published in the January 2014 issue of the American Heart Journal...
View ArticleEsperion Therapeutics Announces the Appointment of Antonio M. Gotto Jr. M.D....
Esperion Therapeutics Inc. Nasdaq ESPR a clinicalstage biopharmaceutical company focused on developing and commercializing firstinclass oral lowdensity lipoprotein cholesterol LDLC lowering therapies...
View ArticleLipitor Lawsuit News Pfizer Inc. Named in Whistleblower Lawsuit Alleging...
The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes allegedly due to Lipitor.New York NY PRWEB January 14 2014 As dozens of Lipitor lawsuits...
View ArticleFormulation of Treatment Recommendations for Statins
To the Editor Drs Ridker and Wilson proposed that statin guidelines formulate treatment recommendations through consideration of patient populations for whom clinical trials have demonstrated benefit....
View ArticleStatin therapy 'reduces risk of delirium' in ICU patients
Continued use of statins may help prevent delirium in critically ill patients who received the drugs before being admitted according to a UK study.
View ArticleStatin use reduces delirium in critically ill patients
Continued use of statins may help prevent delirium in critically ill patients who received statins before hospital admission according to a new study of 470 intensive care patients in the UK.
View ArticleOngoing Statin Therapy Lowers Risk for Delirium in ICU
Ongoing statin therapy was associated with a reduced risk for dementia in a study of 470 patients treated in a British intensive care unit. Medscape Medical News
View ArticleNo Fortune Teller Needed This Risk Calculator Can Predict How Long A Patient...
Free online risk stratification tool helps doctors to better manage their heart failure patients Critical Diagnostics announced today the release of a paper titled Development of a Novel Heart Failure...
View ArticleStatins Linked to Less Delirium in the ICU
MedPage Today Delirium risk was lower for critically ill patients kept on their preexisting statin therapy an observational study showed.
View ArticleTop stories in health and medicine January 20 2014
FromÂMedPage Today Statins Linked to Less Delirium in the ICU. Delirium risk was lower for critically ill patients kept on their preexisting statin therapy. Few Docs Ready for Stage 2...
View ArticleNovel nanotherapy breakthrough may help reduce recurrent heart attacks stroke
A new report shows that new statin nanotherapy can target highrisk inflammation inside heart arteries that causes heart attacks or
View ArticleNew Cholesterol Guidelines for Statin Drugs in Lexicomp Online Drug Monographs
Wolters Kluwer Health a leading global provider of information for healthcare professionals and students announced today that Lexicomp Online its hospitalwide referential drug information solution has...
View ArticleNovel Nanotherapy Breakthrough May Help Reduce Recurrent Heart Attacks and...
Icahn School of Medicine at Mount Sinai Designs HDL Nanoparticle to Deliver Statin Medication Inside Inflamed Blood Vessels to Prevent Repeat Heart Attacks and StrokeNew York NY PRWEB January 20 2014...
View ArticlePaid High Cholesterol Clinical Trial Now Enrolling at Achieve Clinical...
Achieve is conducting a placebocontrolled study of the efficacy tolerability and safety of a new high cholesterol drug in reducing the occurrence of major cardiovascular CV events in high risk subjects...
View ArticleAmgen Announces Positive TopLine Results From Phase 3 GAUSS2 Trial Of...
THOUSAND OAKS Calif. Jan. 23 2014 PRNewswire &160;Amgen NASDAQAMGN today announced that the Phase 3 GAUSS2 Goal Achievement After Utilizing an AntiPCSK9 Antibody in Statin Intolerant Subjects2...
View ArticleEvolocumab Lowers LDL in StatinIntolerant Patients
Evolocumab an investigational PCSK9 inhibitor successfully lowered LDLcholesterol levels from baseline to week 12 in patients unable to tolerate statins because of side effects. Heartwire
View ArticleAmgen Reports Positive Results From Latestage GAUSS2 Trial Of Evolocumab
THOUSAND OAKS dpaAFX Amgen AMGN announced Thursday that the Phase 3 GAUSS2 or Goal Achievement After Utilizing an AntiPCSK9 Antibody in Statin Intolerant Subjects2 trial evaluating evolo...
View ArticleAmgen cholesterol drug meets goal of third late stage trial
Jan 23 Reuters A cholesterol fighter developed by Amgen Inc from a new class of medicines succeeded in significantly lowering levels of "bad" LDL cholesterol in a late stage trial in patients unable to...
View Article